MAPT and Alzheimer disease: Abolishing tau expression ameliorated the learning and memory impairments as well as the detrimental effects of apoE4(Δ272–299) on hilar GABAergic interneurons, suggesting that tau is a crucial downstream mediator in apoE4-related GABAergic interneuron impairment and AD pathogenesis [28].